2025 Europe Blood Testing Market Revenue Opportunities Report
Description
The 2025 Europe Blood Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European blood testing market are Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, and Grifols. Roche Diagnostics, headquartered in Switzerland, is a major player known for its broad portfolio in clinical diagnostics and blood testing technologies. Siemens Healthineers, based in Germany, has a strong European presence with a wide range of diagnostics equipment and comprehensive clinical laboratory services. Bio-Rad Laboratories, a U.S.-based company, offers extensive blood screening and diagnostic products and has a significant role in the European blood testing sector. Grifols, headquartered in Spain, is notable for its acquisition of key units such as Hologic’s NAT technology for donor screening, enhancing its footprint in Europe.
These companies leverage strategies like product development, mergers and acquisitions, and investments in research and development to maintain market leadership. They cater to rising demands driven by Europe's aging population, increasing chronic diseases, and the need for advanced diagnostics in oncology, cardiovascular, and infectious diseases. Additionally, companies like NOUL and Eurofins Scientific, alongside SYNLAB and Unilabs, are expanding their operations within Europe, deploying AI-powered diagnostics and integrated testing platforms to capture growing demands for rapid, multi-panel, and point-of-care testing. These four leaders benefit from strong local regulatory compliance, evidenced by CE-IVD certifications and strategic clinical collaborations across Germany, France, and the UK.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the European blood testing market are Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, and Grifols. Roche Diagnostics, headquartered in Switzerland, is a major player known for its broad portfolio in clinical diagnostics and blood testing technologies. Siemens Healthineers, based in Germany, has a strong European presence with a wide range of diagnostics equipment and comprehensive clinical laboratory services. Bio-Rad Laboratories, a U.S.-based company, offers extensive blood screening and diagnostic products and has a significant role in the European blood testing sector. Grifols, headquartered in Spain, is notable for its acquisition of key units such as Hologic’s NAT technology for donor screening, enhancing its footprint in Europe.
These companies leverage strategies like product development, mergers and acquisitions, and investments in research and development to maintain market leadership. They cater to rising demands driven by Europe's aging population, increasing chronic diseases, and the need for advanced diagnostics in oncology, cardiovascular, and infectious diseases. Additionally, companies like NOUL and Eurofins Scientific, alongside SYNLAB and Unilabs, are expanding their operations within Europe, deploying AI-powered diagnostics and integrated testing platforms to capture growing demands for rapid, multi-panel, and point-of-care testing. These four leaders benefit from strong local regulatory compliance, evidenced by CE-IVD certifications and strategic clinical collaborations across Germany, France, and the UK.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
